Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Boracchi

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
European Journal of Cancer. Part B, Oral Oncology|October 1, 1992
Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary resultsF Chiesa, N Tradati, M Marazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapyR Silvestrini, M G Daidone, M Mastore, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
Tumori|June 30, 1989
Adjuvant chemotherapy with fluorouracil and CCNU in colon cancer. Results of a multicentric randomized studyM Marangolo, G Pezzuoli, E Marubini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.
British Journal of Cancer|July 17, 2003
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifenD Coradini, E Biganzoli, C Pellizzaro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trialU Veronesi, A Banfi, B Salvadori, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Fenretinide (4-HPR) in chemoprevention of oral leukoplakiaF Chiesa, N Tradati, M Marazza, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Cancer. Part B, Oral Oncology|October 1, 1992
Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary resultsF Chiesa, N Tradati, M Marazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapyR Silvestrini, M G Daidone, M Mastore, et al.
Journal of the National Cancer Institute|April 6, 1994
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patientsR Silvestrini, S Veneroni, M G Daidone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
Tumori|June 30, 1989
Adjuvant chemotherapy with fluorouracil and CCNU in colon cancer. Results of a multicentric randomized studyM Marangolo, G Pezzuoli, E Marubini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.
British Journal of Cancer|July 17, 2003
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifenD Coradini, E Biganzoli, C Pellizzaro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trialU Veronesi, A Banfi, B Salvadori, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Fenretinide (4-HPR) in chemoprevention of oral leukoplakiaF Chiesa, N Tradati, M Marazza, et al.
Pageof 12